Who is running the CDC temporarily?

Who stepped in and what to expect

Leadership at the U.S. Centers for Disease Control and Prevention has shifted temporarily: the director of the National Institutes of Health is taking on an acting role at the CDC while the administration seeks a permanent head. The move concentrates senior responsibility for two major federal public-health agencies in one official for the short term.

Why this matters

The CDC guides disease surveillance, outbreak response, immunization recommendations and many emergency-preparedness activities. When a single person holds leadership roles across agencies, decisions about priorities, staffing and policy can change more quickly—especially on high-profile topics like vaccines, pandemic preparation and funding for research. Several reporting threads note concern among public-health experts about the pace and direction of policy under the current administration.

Immediate signals and consequences

• Advisory committees and meetings related to vaccines and public-health guidance have been postponed or rescheduled, affecting the timing of recommendations.
• Observers are watching whether the temporary leader will align CDC actions with broader health-department priorities.
• Vacancies at senior roles across federal health agencies remain substantial, which can complicate routine operations and long-term planning.

What to watch next

• Whether postponed advisory panels are reconvened and with what agendas.
• Any near-term shifts in vaccine policy, surveillance priorities or funding allocations.
• Appointments to permanent leadership slots at both agencies.

In the short term, public-health professionals and state health departments are monitoring how the dual-role arrangement affects responsiveness to outbreaks and the continuity of routine CDC functions.